Peptide Stack Design Basics: How to Think About Multi-Compound Protocols

Why stacks exist

A "stack" is a deliberate combination of two or more compounds chosen to produce complementary or synergistic effects. The reason stacks exist: most goals are multi-system. Recovery isn't just inflammation; it's also tissue repair plus circulation plus rest quality. Body composition isn't just fat loss; it's also lean mass preservation plus recovery from training plus appetite regulation. Single-compound protocols address one mechanism; stacks address multiple.

Stack design is not "take more compounds = better outcomes." It's choosing compounds whose mechanisms cover different parts of the goal without redundancy or conflict, then sequencing them properly. This article covers how to think about that design — not which specific stack to run.

Three principles of stack design

Principle 1: Complementary mechanisms

Two compounds with overlapping mechanisms add risk without adding effect. Two compounds with different mechanisms can address different parts of the goal.

Example — recovery stack: BPC-157 works through nitric oxide signaling and growth factor upregulation. TB-500 works through actin sequestration and angiogenesis. Different pathways. Stacking them addresses both signals; running both is mechanistically justified.

Counter-example — redundant: running BPC-157 + another peptide that also operates through the NO pathway adds little because the limiting factor isn't the signal, it's the response. Two signals into a saturated receptor system don't double the output.

Principle 2: Cadence and timing compatibility

Compounds that require fasted-state injection (CJC-1295/Ipamorelin) constrain your day differently than compounds that don't (BPC-157, GLP-1s). Daily compounds add tracking burden that weekly compounds don't.

A well-designed stack considers whether the cadence and timing requirements of each compound are compatible with the others and with your actual life. A protocol that requires three different fasted windows per day is theoretically possible but practically unworkable for most people.

Principle 3: Half-life awareness

Compounds with very different half-lives produce different protocol shapes:

• Short half-life (BPC-157, CJC no-DAC): need frequent dosing; produce sharp pulses; accumulate minimally
• Medium half-life (Ipamorelin, TB-500): once-daily to twice-weekly; some accumulation
• Long half-life (CJC with DAC, semaglutide, tirzepatide): weekly or longer; significant accumulation; long washout

A stack mixing these is normal — but the half-life chart for the stack will look complex (BPC's daily pulses on top of TB-500's weekly accumulation on top of tirzepatide's slow rise to steady state). Use the half-life chart to visualize your specific stack.

Common stack archetypes

Recovery stack

• BPC-157 (daily) — tissue protection / repair
• TB-500 (twice weekly loading, then weekly maintenance) — angiogenesis, cell migration
• Optional: CJC-1295/Ipamorelin (daily fasted) — GH-axis support for additional anabolic signaling

See the full recovery stack protocol guide.

GH pulse stack

• CJC-1295 (no DAC) + Ipamorelin (daily fasted, morning and/or evening) — dual-pathway GH pulse amplification

Single goal, two compounds. The GH stack is technically not multi-system — but it uses two compounds for the dual-pathway synergy at the pituitary (GHRH receptor + GHS-R). See the GH secretagogue guide.

Body composition stack (during GLP-1 therapy)

• GLP-1 agonist (weekly) — appetite suppression, weight loss
• BPC-157 (daily) — recovery from increased training volume
• Optional: CJC-1295/Ipamorelin (daily fasted) — lean mass preservation support

Bridges the GLP-1 user toward broader optimization. See the GLP-1-to-peptides bridge article.

Longevity stack

• NAD+ or NMN — cellular energy, sirtuin support
• BPC-157 — tissue repair, "biological resilience"
• CJC-1295/Ipamorelin — anabolic / body composition
• Optional: Low-dose GLP-1 agonist — metabolic / cardiovascular
• Optional: Thymosin Alpha-1 — immune modulation (pulsed)

The largest and most complex of the common stacks. See the longevity peptide stack overview.

What goes wrong in stack design

Over-stacking

Adding more compounds doesn't linearly increase outcomes — but it does linearly increase tracking complexity, side effect surface area, and cost. A 5-compound stack is not 5× better than a 1-compound protocol; it might be marginally better with substantially more risk and friction.

Cadence chaos

Three compounds with three different cadences (daily, twice weekly, weekly) is manageable. Five compounds with five different schedules typically exceeds working memory. Missed doses, dose calculation errors, and inadequate site rotation multiply.

Timing conflicts

Stacking compounds that compete for the same scarce resource — your fasted morning window — without adequate spacing dilutes effectiveness. CJC/Ipa requires fasted state; if you also want fasted-state cardio, fasted-state coffee, and fasted-state anything else, the morning becomes a bottleneck.

Inadequate site rotation

Daily injections + multiple daily compounds means more injections per week. Lipohypertrophy from inadequate site rotation reduces absorption — which silently reduces protocol effectiveness. The more compounds, the more critical site rotation becomes.

No exit plan

Most protocols need a stop or reassessment point. "What's the plan if BPC-157 doesn't help my injury after 8 weeks?" is a question to answer before starting, not after. Open-ended protocols accumulate complexity without checkpoints.

Stack design questions to bring to your provider

Before starting a multi-compound stack:

1. What specific goal does each compound address?
2. Are any of these compounds redundant (same mechanism)?
3. Are there timing or interaction conflicts?
4. What's the protocol length, and what are the assessment checkpoints?
5. What's the exit plan — when do we stop or modify?
6. What are the monitoring labs, side effect markers, or other parameters?

A provider who can't answer these questions for the specific stack they're prescribing is a yellow flag. Stacks are clinical decisions, not protocols you assemble from forum posts.

Tracking is what makes stacks workable

The difference between a workable stack and a chaotic one is usually tracking infrastructure. With each compound logged accurately — dose, date, site, timing — you can correlate outcomes with what actually happened. Without it, you're guessing about what's working and what isn't.

My Pep Calc was built specifically for the multi-compound case. Each compound has its own log, its own half-life curve, and its own site rotation. The combined view shows your full protocol on one timeline so you (and your provider) have a complete picture.